SURGICAL APPROACH TO SUBRETINAL WASHOUT BIOPSY FOR PRIMARY VITREORETINAL LYMPHOMA.

Retin Cases Brief RepSep 1, 2026

Jordan V Chervenkoff, Giancarlo Dell'Aversana Orabona, Edward Pringle et al.

✦ AI-curated · Sources linked

Case in brief

A patient presented with primary vitreoretinal lymphoma (PVRL) that mimicked vitritis and included subretinal lesions. A combined approach of anterior chamber tap, dry vitreous biopsy, and subretinal washout was utilized for diagnosis. Cytological analysis revealed a clonal B-cell population, and the patient showed significant visual improvement to 6/7.5 at three months post-procedure.

What made this case unusual

The use of subretinal washout and aspiration in conjunction with standard vitreous biopsy for diagnosing PVRL is noteworthy, as it may enhance diagnostic sensitivity.

Diagnostic / clinical pearl

Clinicians should consider subretinal fluid aspiration in cases of suspected PVRL with subretinal lesions to improve diagnostic accuracy.

Why it matters

This case highlights the importance of prompt diagnosis and intervention in PVRL, which can significantly impact visual outcomes.

Source

Published in Retin Cases Brief Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.